JP2011142913A - ウイルス感染に対する抵抗性に関連する遺伝子である、oas1における変異の検出 - Google Patents

ウイルス感染に対する抵抗性に関連する遺伝子である、oas1における変異の検出 Download PDF

Info

Publication number
JP2011142913A
JP2011142913A JP2011021746A JP2011021746A JP2011142913A JP 2011142913 A JP2011142913 A JP 2011142913A JP 2011021746 A JP2011021746 A JP 2011021746A JP 2011021746 A JP2011021746 A JP 2011021746A JP 2011142913 A JP2011142913 A JP 2011142913A
Authority
JP
Japan
Prior art keywords
seq
virus
oas1
polypeptide
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2011021746A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011142913A5 (cg-RX-API-DMAC7.html
Inventor
Shawn P Iadonato
ショーン・ピー・イアドネイト
Charles L Magness
チャールズ・エル・マグネス
Gary Rosenberg
ガリー・ローゼンバーグ
Christina A Scherer
クリスティーナ・エー・シェーラー
Thierry Guillaudeux
チエリー・ギアド
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Illumigen Biosciences Inc
Original Assignee
Illumigen Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Illumigen Biosciences Inc filed Critical Illumigen Biosciences Inc
Publication of JP2011142913A publication Critical patent/JP2011142913A/ja
Publication of JP2011142913A5 publication Critical patent/JP2011142913A5/ja
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Neurology (AREA)
  • Emergency Medicine (AREA)
  • Psychiatry (AREA)
JP2011021746A 2003-10-23 2011-02-03 ウイルス感染に対する抵抗性に関連する遺伝子である、oas1における変異の検出 Withdrawn JP2011142913A (ja)

Applications Claiming Priority (14)

Application Number Priority Date Filing Date Title
US51388803P 2003-10-23 2003-10-23
US60/513,888 2003-10-23
US54237304P 2004-02-06 2004-02-06
US60/542,373 2004-02-06
US55475804P 2004-03-19 2004-03-19
US60/554,758 2004-03-19
US56052404P 2004-04-08 2004-04-08
US60/560,524 2004-04-08
US57832304P 2004-06-09 2004-06-09
US60/578,323 2004-06-09
US58350304P 2004-06-28 2004-06-28
US60/583,503 2004-06-28
US60524304P 2004-08-26 2004-08-26
US60/605,243 2004-08-26

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2006536883A Division JP2007529199A (ja) 2003-10-23 2004-10-22 ウイルス感染に対する抵抗性に関連する遺伝子である、oas1における変異の検出

Publications (2)

Publication Number Publication Date
JP2011142913A true JP2011142913A (ja) 2011-07-28
JP2011142913A5 JP2011142913A5 (cg-RX-API-DMAC7.html) 2012-05-17

Family

ID=42331514

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2011021746A Withdrawn JP2011142913A (ja) 2003-10-23 2011-02-03 ウイルス感染に対する抵抗性に関連する遺伝子である、oas1における変異の検出
JP2012111782A Pending JP2012183069A (ja) 2003-10-23 2012-05-15 ウイルス感染に対する抵抗性に関連する遺伝子である、oas1における変異の検出
JP2013097618A Pending JP2013208117A (ja) 2003-10-23 2013-05-07 ウイルス感染に対する抵抗性に関連する遺伝子である、oas1における変異の検出

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2012111782A Pending JP2012183069A (ja) 2003-10-23 2012-05-15 ウイルス感染に対する抵抗性に関連する遺伝子である、oas1における変異の検出
JP2013097618A Pending JP2013208117A (ja) 2003-10-23 2013-05-07 ウイルス感染に対する抵抗性に関連する遺伝子である、oas1における変異の検出

Country Status (4)

Country Link
US (1) US20050191649A1 (cg-RX-API-DMAC7.html)
JP (3) JP2011142913A (cg-RX-API-DMAC7.html)
IL (1) IL175089A (cg-RX-API-DMAC7.html)
NZ (3) NZ591879A (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0415771A (pt) 2003-10-23 2006-12-26 Illumigen Biosciences Inc detecção de mutações em um gene associado à resistência a infecção viral, oas1
UA95446C2 (ru) 2005-05-04 2011-08-10 Іллюміджен Байосайєнсіз, Інк. Мутаци в генах oas1
US11439689B2 (en) * 2016-11-14 2022-09-13 Kaohsiung Medical University Method for detecting whether glucose metabolism is abnormal, and prevention and treatment therefor

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863873A (en) * 1980-01-14 1989-09-05 Esa, Inc. Method for biological testing and/or developing pharmaceuticals for treatment of disorders
US5266459A (en) * 1992-02-24 1993-11-30 The Scripps Research Institute Gaucher's disease: detection of a new mutation in intron 2 of the glucocerebrosidase gene
US5597709A (en) * 1994-01-27 1997-01-28 Human Genome Sciences, Inc. Human growth hormone splice variants hGHV-2(88) and hGHV-3(53)
US5840565A (en) * 1995-08-22 1998-11-24 The Regents Of The University Of California Methods for enhancing the production of viral vaccines in PKR-deficient cell culture
AU3367799A (en) * 1998-03-30 1999-10-18 Esa Inc. Methodology for predicting and/or diagnosing disease
US20010034023A1 (en) * 1999-04-26 2001-10-25 Stanton Vincent P. Gene sequence variations with utility in determining the treatment of disease, in genes relating to drug processing
US20030165921A1 (en) * 2000-02-03 2003-09-04 Tang Y. Tom Novel nucleic acids and polypeptides
AU2001245619A1 (en) * 2000-03-09 2001-09-17 Chiron Corporation Human genes and gene expression products
AU2002341207A1 (en) * 2001-05-08 2002-11-18 Switch Biotech Ag Use of 2'-5'-oligoadenylate synthetase and/or rnasel or nucleic acids encoding them for diagnosis, prophylaxis or treatment of wound healing
US6818420B2 (en) * 2002-02-27 2004-11-16 Biosource International, Inc. Methods of using FET labeled oligonucleotides that include a 3′-5′ exonuclease resistant quencher domain and compositions for practicing the same
US7354908B2 (en) * 2002-04-30 2008-04-08 University Of South Florida Materials and methods for prevention and treatment of RNA viral diseases
WO2004044124A2 (en) * 2002-05-17 2004-05-27 Baylor College Of Medicine Identification of oligoadenylate synthetase-like genes

Also Published As

Publication number Publication date
NZ603105A (en) 2014-08-29
JP2013208117A (ja) 2013-10-10
NZ591879A (en) 2012-11-30
IL175089A (en) 2013-10-31
IL175089A0 (en) 2006-08-20
US20050191649A1 (en) 2005-09-01
NZ580169A (en) 2011-04-29
JP2012183069A (ja) 2012-09-27

Similar Documents

Publication Publication Date Title
US9090947B2 (en) Detection of mutations in a gene associated with resistance to viral infection, OAS1
JP2013208117A (ja) ウイルス感染に対する抵抗性に関連する遺伝子である、oas1における変異の検出
AU2006242152B2 (en) Mutations in OAS1 genes
US20070111231A1 (en) Detection of mutations in a gene associated with resistance to viral infection, OAS2 and OAS3
AU2013228050B2 (en) Detection of mutations in a gene associated with resistance to viral infection, oas1
US20090186028A1 (en) Detection of mutations in a gene associated with resistance to viral infection
US20090155234A1 (en) Detection of mutations in a gene associated with resistance to viral infection, mx1
TWI415944B (zh) 偵測與病毒感染抗性有關基因(oasi)中之突變之方法
HK1151186A (en) Oligoadenylate synthetase
MXPA06004493A (en) Detection of mutations in a gene associated with resistance to viral infection, oas1
HK1161740B (en) Detection of mutations in a gene associated with resistance to viral infection, oas1
HK1193351A (en) Detection of mutations in a gene associated with resistance to viral infection, oas1

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20110304

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110524

A072 Dismissal of procedure [no reply to invitation to correct request for examination]

Free format text: JAPANESE INTERMEDIATE CODE: A073

Effective date: 20120717

A300 Application deemed to be withdrawn because no request for examination was validly filed

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20120807